Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics MarketGroup PsychotherapyUpdated on Jun 27, 2019 View more like this | Visit ANCHORAGE, AK | Contact Market Data Forecast |
Recent Developments
Caremark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Caremark concentrated on the treatment of Autism and other neurological diseases. Current prescription medications and psychosocial therapies concentrate on ameliorating primary symptoms. No currently certified drug treats the underlying cause of ADHD, and there is no known cure. Caremark pipeline includes a Phase III-ready drug product for ADHD. Preliminary studies with patients diagnosed with ADHD and taking prescribed ADHD medication show that these children could benefit from the administration of our product, CM-4612.
To know more read: https://marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market
Market Segmentations
Market Data Forecast published a report named Global Attention deficit hyperactivity disorder (ADHD) therapeutics market. It is valued USD 16.09 Billion in 2018 and is expected to reach USD 10.46 Billion by 2023 with a CAGR of 9.00%
Report is segmented by
Stimulants
Amphetamines
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
Age Group
pediatric adolescent,
adults.
Lisdexamfetamine Dimesylate segment expected to increase significantly over the forecast period. The adult's age group segment accounted for the highest revenue share of 50.4% in 2015 and is assumed to retain its dominance throughout the forecast period.
Geographical Segmentation:
Geographically, the global attention deficit hyperactivity disorder (ADHD) therapeutics market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America led the highest share of 36.0% of the global attention deficit hyperactivity disorder (ADHD) therapeutics market in 2018, whereas Asia-Pacific is predicted to grow at the highest CAGR of 12.30% during the forecast period 2018-2023.
Key market players in the market are –
Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.),
Eli Lilly and Company (U.S.),
Pfizer Inc. (U.S.), Alcobra Ltd. (Israel),
Supernus Pharmaceuticals, Inc. (U.S.).
View sample and decide: https://marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market/request-sample
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-962
Caremark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Caremark concentrated on the treatment of Autism and other neurological diseases. Current prescription medications and psychosocial therapies concentrate on ameliorating primary symptoms. No currently certified drug treats the underlying cause of ADHD, and there is no known cure. Caremark pipeline includes a Phase III-ready drug product for ADHD. Preliminary studies with patients diagnosed with ADHD and taking prescribed ADHD medication show that these children could benefit from the administration of our product, CM-4612.
To know more read: https://marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market
Market Segmentations
Market Data Forecast published a report named Global Attention deficit hyperactivity disorder (ADHD) therapeutics market. It is valued USD 16.09 Billion in 2018 and is expected to reach USD 10.46 Billion by 2023 with a CAGR of 9.00%
Report is segmented by
Stimulants
Amphetamines
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
Age Group
pediatric adolescent,
adults.
Lisdexamfetamine Dimesylate segment expected to increase significantly over the forecast period. The adult's age group segment accounted for the highest revenue share of 50.4% in 2015 and is assumed to retain its dominance throughout the forecast period.
Geographical Segmentation:
Geographically, the global attention deficit hyperactivity disorder (ADHD) therapeutics market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America led the highest share of 36.0% of the global attention deficit hyperactivity disorder (ADHD) therapeutics market in 2018, whereas Asia-Pacific is predicted to grow at the highest CAGR of 12.30% during the forecast period 2018-2023.
Key market players in the market are –
Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.),
Eli Lilly and Company (U.S.),
Pfizer Inc. (U.S.), Alcobra Ltd. (Israel),
Supernus Pharmaceuticals, Inc. (U.S.).
View sample and decide: https://marketdataforecast.com/market-reports/attention-deficit-hyperactivity-disorder-therapeutics-market/request-sample
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Info:
Name: Mr. Abhishek Shukla
Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-962
